These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12496759)

  • 21. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.
    Lucas GJ; Mehta SG; Hocking LJ; Stewart TL; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Watts GD; Ralston SH; Kimonis VE
    Bone; 2006 Feb; 38(2):280-5. PubMed ID: 16199218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.
    Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P
    J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations.
    Kang HR; Yim EY; Oh SY; Chang YS; Kim YK; Cho SH; Min KU; Kim YY
    Allergy; 2006 Feb; 61(2):260-4. PubMed ID: 16409206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease.
    Zimprich A; Asmus F; Leitner P; Castro M; Bereznai B; Homann N; Ott E; Rutgers AW; Wieditz G; Trenkwalder C; Gasser T
    Neurogenetics; 2003 Aug; 4(4):219-20. PubMed ID: 12827450
    [No Abstract]   [Full Text] [Related]  

  • 25. NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study.
    Ruano D; Macedo A; Dourado A; Soares MJ; Valente J; Coelho I; Santos V; Azevedo MH; Goodman A; Hutz MH; Gama C; Lobato MI; Belmonte-de-Abreu P; Palha JA
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):41-5. PubMed ID: 15211629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease.
    Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.
    Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O
    Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038
    [No Abstract]   [Full Text] [Related]  

  • 28. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.
    Healy DG; Abou-Sleiman PM; Ahmadi KR; Gandhi S; Muqit MM; Bhatia KP; Quinn NP; Lees AJ; Holton JL; Revesz T; Wood NW
    Mov Disord; 2006 Nov; 21(11):1960-3. PubMed ID: 16977628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population.
    Meeus B; Nuytemans K; Crosiers D; Engelborghs S; Pals P; Pickut B; Peeters K; Mattheijssens M; Corsmit E; Cras P; De Deyn PP; Theuns J; Van Broeckhoven C
    Neurobiol Aging; 2011 Feb; 32(2):308-12. PubMed ID: 19321232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder.
    Smith KM; Bauer L; Fischer M; Barkley R; Navia BA
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):57-63. PubMed ID: 15635701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
    Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C
    Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merging mouse transcriptome analyses with Parkinson's disease linkage studies.
    Gherbassi D; Bhatt L; Thuret S; Simon HH
    DNA Res; 2007 Apr; 14(2):79-89. PubMed ID: 17522092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
    Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH
    Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nurr1 mutational screen in Parkinson's disease.
    Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y
    Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
    Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A
    Neurotox Res; 2016 Oct; 30(3):338-44. PubMed ID: 27159982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortalin mutations are not a frequent cause of early-onset Parkinson disease.
    Freimann K; Zschiedrich K; Brüggemann N; Grünewald A; Pawlack H; Hagenah J; Lohmann K; Klein C; Westenberger A
    Neurobiol Aging; 2013 Nov; 34(11):2694.e19-20. PubMed ID: 23831374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia.
    Emelyanov A; Boukina T; Yakimovskii A; Usenko T; Drosdova A; Zakharchuk A; Andoskin P; Dubina M; Schwarzman A; Pchelina S
    Mov Disord; 2012 Jan; 27(1):158-9. PubMed ID: 21915911
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic analysis of NR4A2 gene in a large population of Han Chinese patients with Parkinson's disease.
    Liu H; Tao Q; Deng H; Ming M; Ding Y; Xu P; Chen S; Song Z; Le W
    Eur J Neurol; 2013 Mar; 20(3):584-587. PubMed ID: 22827504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients.
    Chen YH; Tsai MT; Shaw CK; Chen CH
    Am J Med Genet; 2001 Dec; 105(8):753-7. PubMed ID: 11803525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of haplotypes derived from three common variants of the NR4A2 gene in Japanese patients with schizophrenia.
    Iwayama-Shigeno Y; Yamada K; Toyota T; Shimizu H; Hattori E; Yoshitsugu K; Fujisawa T; Yoshida Y; Kobayashi T; Toru M; Kurumaji A; Detera-Wadleigh S; Yoshikawa T
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):20-4. PubMed ID: 12627459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.